BRIEF-Adocia and Lilly initiate phase 1b study evaluating BioChaperone Lispro
October 06, 2015 at 01:40 AM EDT
* Adocia and Eli Lilly and Company initiate a phase 1b study evaluating ultra-rapid BioChaperone Lispro in patients with type 1 diabetes using insulin pump therapy
